Abcam plc, commonly known as Abcam, is a leading life sciences company headquartered in Cambridge, GB. Founded in 1998, Abcam has established itself as a prominent player in the biotechnology industry, specialising in the production and distribution of high-quality antibodies and related products. With a strong focus on research and development, the company serves a global market, with significant operations across Europe, North America, and Asia. Abcam's core offerings include a vast range of antibodies, proteins, and assays, which are renowned for their specificity and reliability. The company’s commitment to innovation and quality has positioned it as a trusted partner for researchers in academia and industry alike. Notable achievements include a robust portfolio of over one million products, making Abcam a go-to resource for scientists seeking advanced tools for their research.
How does Abcam's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abcam's score of 55 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Abcam's carbon emissions in Great Britain totalled approximately 659,000 kg CO2e, comprising 289,000 kg CO2e from Scope 1 and 370,000 kg CO2e from Scope 2. This reflects a significant reduction from 2021, when emissions were about 1,272,000 kg CO2e (494,000 kg CO2e from Scope 1 and 778,000 kg CO2e from Scope 2). Globally, Abcam reported total emissions of about 102,263,000 kg CO2e in 2022, with Scope 1 emissions at 1,224,000 kg CO2e, Scope 2 at 3,370,000 kg CO2e, and Scope 3 emissions at approximately 97,669,000 kg CO2e. This data indicates a comprehensive approach to emissions reporting, including all three scopes. Despite the substantial emissions figures, there are currently no specific reduction targets or climate pledges disclosed by Abcam. The emissions data is cascaded from their parent company, Danaher Corporation, indicating a corporate commitment to sustainability at multiple levels. Abcam's ongoing efforts to manage and reduce carbon emissions align with industry standards, although further details on specific initiatives or targets are not available at this time.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,554,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,198,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,752,000 | 00,000,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abcam has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.